Sanofi/Regeneron’s Kevzara fails again in serious COVID-19 casesSanofi has drawn another blank in its attempt to repurpose its IL-6 drug Kevzara to tackle the extreme Share XSanofi/Regeneron’s Kevzara fails again in serious COVID-19 caseshttps://pharmaphorum.com/news/sanofi-regenerons-kevzara-fails-again-in-serious-covid-19-cases/
IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trialHopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results Share XIL-6 hypothesis looking shaky as Kevzara fails COVID-19 trialhttps://pharmaphorum.com/news/il-6-hypothesis-looking-shaky-as-kevzara-fails-covid-19-trial/
